Fviii + ConcizumabMajor
High and/or frequent doses increase risk of thromboembolism. Lowest-approved dose recommended for mild to moderate bleeds.
Source: NLP:concizumab
Fviii Interactions
1 interaction on record
1 interaction on record
High and/or frequent doses increase risk of thromboembolism. Lowest-approved dose recommended for mild to moderate bleeds.
Source: NLP:concizumab